| Matthew Allen Shaver, MD | |
|
105 Yadkin St, Ste 203, Albemarle, NC 28001-3449 | |
| (980) 323-5300 | |
| Not Available |
| Full Name | Matthew Allen Shaver |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 15 Years |
| Location | 105 Yadkin St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750518718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2014-01085 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stanly Regional Medical Center | Albemarle, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
A scientifically tested digital intervention created by the University of Southampton has already proved to be effective at reducing the spread of viral respiratory tract infections – such as colds and flu.
Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
Learning appears to slow the development of two brain lesions that are the hallmarks of Alzheimer's disease, scientists at UC Irvine have discovered. The finding suggests that the elderly, by keeping their minds active, can help delay the onset of this degenerative disease.
› Verified 4 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
A scientifically tested digital intervention created by the University of Southampton has already proved to be effective at reducing the spread of viral respiratory tract infections – such as colds and flu.
Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
Learning appears to slow the development of two brain lesions that are the hallmarks of Alzheimer's disease, scientists at UC Irvine have discovered. The finding suggests that the elderly, by keeping their minds active, can help delay the onset of this degenerative disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Allen Shaver, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Matthew Allen Shaver, MD 105 Yadkin St, Ste 203, Albemarle, NC 28001-3449 Ph: (980) 323-5300 |
News Archive
A scientifically tested digital intervention created by the University of Southampton has already proved to be effective at reducing the spread of viral respiratory tract infections – such as colds and flu.
Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
Learning appears to slow the development of two brain lesions that are the hallmarks of Alzheimer's disease, scientists at UC Irvine have discovered. The finding suggests that the elderly, by keeping their minds active, can help delay the onset of this degenerative disease.
› Verified 4 days ago
Alla Zemlyak, MD Surgery Medicare: Medicare Enrolled Practice Location: 105 Yadkin St, Ste 203, Albemarle, NC 28001 Phone: 980-323-5300 | |
Jason M Arru, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 Yadkin St, Ste 203, Albemarle, NC 28001 Phone: 980-323-5300 | |
David Lipsi, Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 Yadkin St, Suite 203, Albemarle, NC 28001 Phone: 980-323-5300 | |
Mouza Goova, Surgery Medicare: Medicare Enrolled Practice Location: 105 Yadkin St, Suite 203, Albemarle, NC 28001 Phone: 980-323-5300 | |
Winston Godwin, Surgery Medicare: Medicare Enrolled Practice Location: 105 Yadkin St, Suite 203, Albemarle, NC 28001 Phone: 980-323-5300 | |
Dennis F Devereux, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 Yadkin St, Suite 203, Albemarle, NC 28001 Phone: 704-982-0161 |